SCHEMBL5409138

SCHEMBL5409138

CN(C(=O)c1ccccc1-c1ccccc1C(=O)N(CCC(=O)O)Cc1ccc(F)cc1)c1cccs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39
LPAR1 Q92633 3/20 0.38
TDP1 Q9NUW8 1/20 0.38
LTB4R2 Q9NPC1 2/20 0.37
POLB P06746 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
LMNA P02545 2/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
F2 P00734 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5402960 0.93 ALDH1A1 (0.43) ALDH1A1LPAR1TDP1LTB4R2POLB
SCHEMBL5399597 0.89 ALDH1A1 (0.49) ALDH1A1MAPTLPAR1TDP1POLB
SCHEMBL5411836 0.84 KCNA5 (0.43) ALDH1A1MAPTHTTKMT2ALMNA
SCHEMBL5407120 0.84 KMT2A (0.41) ALDH1A1TDP1LTB4R2POLBMEN1
SCHEMBL5404063 0.83 KDM4A (0.40) ALDH1A1MAPTLPAR1TDP1LTB4R2
SCHEMBL5409193 0.83 TSHR (0.43) ALDH1A1TDP1POLBMEN1KMT2A
SCHEMBL5399037 0.82 TRPM8 (0.39) ALDH1A1LPAR1TDP1MEN1KMT2A
SCHEMBL5398893 0.82 KMT2A (0.56) ALDH1A1MAPTLPAR1TDP1MEN1
SCHEMBL5402850 0.82 MEN1 (0.46) ALDH1A1LPAR1TDP1LTB4R2MEN1
SCHEMBL5397305 0.81 TSHR (0.54) LPAR1LTB4R2LMNAHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285680-B2 β-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-10-23 US disclosed
US-20050256160-A1 Beta-alanine derivatives and the use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2005-11-17 US disclosed
EP-1533294-A1 BETA-ALANINE DERIVATIVE AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-05-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050256160-A1 Beta-alanine derivatives and the use thereof TGFB1, PML, APOB ALDH1A1 1256/4885MAPT 457/4885HTT 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.